<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Psychiatry">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Psychiatry</JournalTitle>
      <Issn>1735-4587</Issn>
      <Volume>20</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2025</Year>
        <Month>01</Month>
        <Day>31</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Effects of B Vitamins on Symptoms and Cognitive Functions in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial</title>
    <FirstPage>3</FirstPage>
    <LastPage>11</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Somayeh</FirstName>
        <LastName>Agmashe</LastName>
        <affiliation locale="en_US">Department of Psychiatry, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Gita</FirstName>
        <LastName>Sadighi</LastName>
        <affiliation locale="en_US">Psychosis Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Narges</FirstName>
        <LastName>Radman</LastName>
        <affiliation locale="en_US">Department of Psychiatry, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Robabeh</FirstName>
        <LastName>Mazinani</LastName>
        <affiliation locale="en_US">Psychosis Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>02</Month>
        <Day>10</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>11</Month>
        <Day>05</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Objective: Schizophrenia which is a chronic disabling burdensome psychotic disorder has been treated with different antipsychotic medications. Some studies have reported a possible correlation between deficiency in minerals, nutrients and vitamins &#x2014; mainly group B vitamins &#x2014; and the development of schizophrenia. In the present study, we aimed to examine the effect of the B vitamin group as an adjuvant treatment to antipsychotics in individuals with chronic schizophrenia.
Method: In a randomized, double-blind clinical trial study, involving two groups of 25 patients with chronic schizophrenia, we compared the effects of a 12-week adjuvant treatment with a combination of B vitamins &#x2014; B1 (15mg), B2 (15mg), B6 (10mg), B12 (10&#xB5;g) and nicotinamide (50 mg) &#x2014; with a placebo. The impact on negative, positive and cognitive symptoms of schizophrenia was assessed for both groups before the intervention (T0) and at 4, 8 and 12 weeks after the intervention (T1, T2, and T3, respectively).
Results: Following the treatment, negative symptoms scores decreased in the treatment group at 12 weeks following the beginning of the treatment (F (4, 45) = 464.7, P &lt; 0.0001). Although a trend toward improvement in positive symptoms and cognitive scores was seen, these changes were not significant.
Conclusion: Our results suggest that selecting the group B vitamins as an adjuvant treatment to the antipsychotics may have beneficial effects on improving negative symptoms of patients with chronic schizophrenia.</abstract>
    <web_url>https://ijps.tums.ac.ir/index.php/ijps/article/view/3798</web_url>
  </Article>
</Articles>
